Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Scand J Immunol ; 93(6): e13039, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1133093

ABSTRACT

COVID-19 is highly transmissible; however, its severity varies from one individual to another. Variability among different isolates of the virus and among its receptor (ACE2) may contribute to this severity, but comorbidity plays a major role on disease prognosis. Many comorbidities have been reported to be associated with severe COVID-19 patients. We have collected data from retrospective studies which include clinical and epidemiological features of patients and categorize them into severe/mild, ICU/non-ICU and survivors/dead patients. In this review, we give an update about SARS-CoV-2 structure with emphasis on the possible reasons for the severity of the virus in patients. We also collected information and patients' data to highlight the relation between COVID-19 patients and comorbidities.


Subject(s)
COVID-19/virology , Disease Susceptibility , SARS-CoV-2/physiology , Biomarkers , COVID-19/diagnosis , COVID-19/immunology , COVID-19/metabolism , Comorbidity , Cytokines/metabolism , Disease Management , Disease Outbreaks , Genome, Viral , Genomics/methods , Host-Pathogen Interactions/immunology , Humans , Inflammation Mediators/metabolism , Prognosis , Risk Factors , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL